Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Nipah virus/HeV Protein N/Nucleoprotein Polyclonal Antibody

Catalog #:   PVV16601 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Overview

Catalog No.

PVV16601

Species reactivity

Nipah virus(HeV)

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Nipah virus/HeV Protein N/Nucleoprotein (Thr32-Val532).

Tested applications

ELISA: 1:4000-1:8000, IHC:1:50-1:200, WB: 1:1000-1:4000

Target

Nucleoprotein, Protein N, Nucleocapsid protein, N

Concentration

1.87 mg/ml

Purification

Purified by antigen affinity column.

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with Protein N/Nucleoprotein antibody (PVV16601) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 57 kDa
    Observed MW: 57 kDa
References

Cell-Free Expression of Nipah Virus Transmembrane Proteins for Proteoliposome Vaccine Design., PMID:40458951

An Intein-Spliced Nipah G Protein Ferritin Nanoparticle Vaccine Provides Complete Protection against Lethal Nipah Virus Challenge., PMID:40455749

Comprehensive immunoinformatics and bioinformatics strategies for designing a multi-epitope based vaccine targeting structural proteins of Nipah virus., PMID:40433372

Construction of Minigenome Replicon of Nipah Virus and Investigation of Biological Activity., PMID:40431718

A deep learning and molecular modeling approach to repurposing Cangrelor as a potential inhibitor of Nipah virus., PMID:40355437

The rising threat of Nipah virus: a highly contagious and deadly zoonotic pathogen., PMID:40349023

Machine learning assisted in Silico discovery and optimization of small molecule inhibitors targeting the Nipah virus glycoprotein., PMID:40341732

Design and Preliminary Immunogenicity Evaluation of Nipah Virus Glycoprotein G Epitope-Based Peptide Vaccine in Mice., PMID:40333318

Ephrin B1 and B2 Mediate Cedar Virus Entry into Egyptian Fruit Bat Cells., PMID:40285015

Implementation of RT-RAA and CRISPR/Cas13a for an NiV Point-of-Care Test: A Promising Tool for Disease Control., PMID:40284926

Viral Fragments in the Urine Proteome: New Clues to the Cause of Fever., PMID:40282183

Computational exploration of viral cell membrane structures for identifying novel therapeutic target., PMID:40175045

Evolutionary trajectories of Nipah virus: Evaluating the antiviral efficacy of Kabasura Kudineer Chooranam., PMID:40174499

Functional and antigenic landscape of the Nipah virus receptor-binding protein., PMID:40132580

Multi-platform omics analysis of Nipah virus infection reveals viral glycoprotein modulation of mitochondria., PMID:40106432

A conserved motif in Henipavirus P/V/W proteins drives the fibrillation of the W protein from Hendra virus., PMID:40100133

Cross-protectivity of henipavirus soluble glycoprotein in an in vivo model of Nipah virus disease., PMID:40078997

Investigating small molecules in propolis as Nipah virus glycoprotein (NiV-G) inhibitors through molecular interaction studies., PMID:40051842

Structural basis of Nipah virus RNA synthesis., PMID:40050611

Serological and molecular analysis of henipavirus infections in synanthropic fruit bat and rodent populations in the Centre and North regions of Cameroon (2018-2020)., PMID:39994638

Molecular modelling of 6-oxo-5-Sulfanyl-1H-Pyridine-3-Carboxylic acid and its adsorption with the silver complex: Structural, optical, charge transference, dynamics and docking to nipah virus., PMID:39965270

Cryo-EM structures of Nipah virus polymerase complex reveal highly varied interactions between L and P proteins among paramyxoviruses., PMID:39964914

Identification of potential therapeutic phytocompounds targeting the G-glycoprotein of Nipah Virus: an in-silico study., PMID:39876783

Development of nebulized inhalation delivery for fusion-inhibitory lipopeptides to protect non-human primates against Nipah-Bangladesh infection., PMID:39870114

Risk of Nipah Virus Seroprevalence in Healthcare Workers: A Systematic Review with Meta-Analysis., PMID:39861870

Molecular modelling and optimization of a high-affinity nanobody targeting the nipah virus fusion protein through in silico site-directed mutagenesis., PMID:39848170

Structural and functional analysis of the Nipah virus polymerase complex., PMID:39837328

Identification of CD8+ Immunogenic Peptides for Vaccine Design against Nipah Virus in Humans., PMID:39759209

Malaysia outbreak survivors retain detectable Nipah antibodies and memory B cells after 25 years., PMID:39755279

The nanoscale organization of the Nipah virus fusion protein informs new membrane fusion mechanisms., PMID:39745781

Structure of the Nipah virus polymerase complex., PMID:39739115

Clinical advancements in mRNA vaccines against viral infections., PMID:39734036

Integrated computational biophysics approach for drug discovery against Nipah virus., PMID:39729673

Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats., PMID:39724110

In silico identification of Nipah virus protein inhibitors from secondary metabolites of medicinal plants using a high-throughput virtual screening approach., PMID:39714114

Structural and antigenic characterization of novel and diverse Henipavirus glycoproteins., PMID:39713338

Functional assessment of the glycoproteins of a novel Hendra virus variant reveals contrasting fusogenic capacities of the receptor-binding and fusion glycoproteins., PMID:39704501

Cryo-EM structure of Nipah virus RNA polymerase complex., PMID:39661676

The E3 ligase RAD18-mediated ubiquitination of henipavirus matrix protein promotes its nuclear-cytoplasmic trafficking and viral egress., PMID:39628457

Cryo-EM structure of Nipah virus L-P polymerase complex., PMID:39627254

Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials., PMID:39549708

Developing a chimeric multiepitope vaccine against Nipah virus (NiV) through immunoinformatics, molecular docking and dynamic simulation approaches., PMID:39521154

Recent report on indoles as a privileged anti-viral scaffold in drug discovery., PMID:39509946

An emerging zoonotic disease to be concerned about - a review of the nipah virus., PMID:39468679

Organotypic brain slices as a model to study the neurotropism of the highly pathogenic Nipah and Ebola viruses., PMID:39466030

Role of RNA G-Quadruplexes in the Japanese Encephalitis Virus Genome and Their Recognition as Prospective Antiviral Targets., PMID:39436355

Abortive infection of bat fibroblasts with SARS-CoV-2., PMID:39401365

How a paramyxovirus fusion/entry complex adapts to escape a neutralizing antibody., PMID:39396053

Structure of the Nipah virus polymerase phosphoprotein complex., PMID:39375338

Tetracistronic minigenomes elucidate a functional promoter for Ghana virus and unveils Cedar virus replicase promiscuity for all henipaviruses., PMID:39345144

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Nipah virus/HeV Protein N/Nucleoprotein Polyclonal Antibody [PVV16601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only